Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand
HONG KONG, Mar 4, 2021 – (ACN Newswire via SEAPRWire.com) – Multinational biopharmaceutical company Alvotech and Gulf FZ LCC (“Cipla Gulf”), subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that they are expanding their partnership for the marketing and distribution of four biosimilar medicines in Australia and New […]